Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission
Cytomegalovirus (CMV) is one of the most common infectious agents, infecting the general population at an early age without causing morbidity most of the time. However, on particular occasions, it may represent a serious risk, as active infection is associated with rejection and disease after solid...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2016/9384813 |
id |
doaj-c2aa85a3588b44fcb73bd1e6e5ed6dfd |
---|---|
record_format |
Article |
spelling |
doaj-c2aa85a3588b44fcb73bd1e6e5ed6dfd2020-11-25T00:15:23ZengHindawi LimitedJournal of Immunology Research2314-88612314-71562016-01-01201610.1155/2016/93848139384813Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical TransmissionGiulia Freer0Paola Quaranta1Mauro Pistello2Retrovirus Center, Department of Translational Research, University of Pisa, Via del Brennero 2, 56127 Pisa, ItalyRetrovirus Center, Department of Translational Research, University of Pisa, Via del Brennero 2, 56127 Pisa, ItalyRetrovirus Center, Department of Translational Research, University of Pisa, Via del Brennero 2, 56127 Pisa, ItalyCytomegalovirus (CMV) is one of the most common infectious agents, infecting the general population at an early age without causing morbidity most of the time. However, on particular occasions, it may represent a serious risk, as active infection is associated with rejection and disease after solid organ transplantation or fetal transmission during pregnancy. Several methods for CMV diagnosis are available on the market, but because infection is so common, careful selection is needed to discriminate primary infection from reactivation. This review focuses on methods based on CMV-specific T cell reactivity to help monitor the consequences of CMV infection/reactivation in specific categories of patients. This review makes an attempt at discussing the pros and cons of the methods available.http://dx.doi.org/10.1155/2016/9384813 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Giulia Freer Paola Quaranta Mauro Pistello |
spellingShingle |
Giulia Freer Paola Quaranta Mauro Pistello Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission Journal of Immunology Research |
author_facet |
Giulia Freer Paola Quaranta Mauro Pistello |
author_sort |
Giulia Freer |
title |
Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission |
title_short |
Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission |
title_full |
Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission |
title_fullStr |
Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission |
title_full_unstemmed |
Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission |
title_sort |
evaluation of t cell immunity against human cytomegalovirus: impact on patient management and risk assessment of vertical transmission |
publisher |
Hindawi Limited |
series |
Journal of Immunology Research |
issn |
2314-8861 2314-7156 |
publishDate |
2016-01-01 |
description |
Cytomegalovirus (CMV) is one of the most common infectious agents, infecting the general population at an early age without causing morbidity most of the time. However, on particular occasions, it may represent a serious risk, as active infection is associated with rejection and disease after solid organ transplantation or fetal transmission during pregnancy. Several methods for CMV diagnosis are available on the market, but because infection is so common, careful selection is needed to discriminate primary infection from reactivation. This review focuses on methods based on CMV-specific T cell reactivity to help monitor the consequences of CMV infection/reactivation in specific categories of patients. This review makes an attempt at discussing the pros and cons of the methods available. |
url |
http://dx.doi.org/10.1155/2016/9384813 |
work_keys_str_mv |
AT giuliafreer evaluationoftcellimmunityagainsthumancytomegalovirusimpactonpatientmanagementandriskassessmentofverticaltransmission AT paolaquaranta evaluationoftcellimmunityagainsthumancytomegalovirusimpactonpatientmanagementandriskassessmentofverticaltransmission AT mauropistello evaluationoftcellimmunityagainsthumancytomegalovirusimpactonpatientmanagementandriskassessmentofverticaltransmission |
_version_ |
1725387177873899520 |